first and family name carmine zoccali date of birth 27...

2
FIRST and FAMILY NAME Carmine Zoccali DATE OF BIRTH 27 th Jan 1947 HIGHEST DEGREE (e.g. full professor, clinical or post- graduate professor, doctor) Post-Graduate Professor of Nephrology HONORS (e.g. FERA, FASN, FAKF, etc.) 1. FERA (Fellow of the European Renal Association) 2. FASN (Fellow of the American Society of Nephrology) 3. FAKF(Fellow of the American Kidney Foundation) PRESENT POSITION Associated Investigator and Research Coordinator CNR-IFC Research on Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, ITALY PRESENT EDITORIAL POSITIONS in International and National Journals (up to seven) As of June 28th , 2017 - Editorial Board member J Am Soc Nephrology - Editorial Board Member Hypertension - Academic editor PlosOne (Public Library of Science, National Institute of Health) - Associate Editor European Journal of Clinical Investigation - Editorial Board member Clinical Nephrology - Editorial Board member Nutrition Metabolism and Cardiovascular Diseases - Editorial Board Member BMC Nephrology AREA OF EXPERTISE (basic, clinical, both) Please also indicate the specific area of interest (e.g. CKD progression, kidney failure, Hypertension, GNitis and Immunopathology, etc.) Hypertension, Cardiovascular Complications in CKD, CKD progression, Epidemiology and Molecular Epidemiology of the risk for CV complications of CKD disease and CKD Progression. NUMBER OF PUBMED PUBLICATIONS As of June 28th, 2017 638 PubMed indexed publications. 5 MOST QUOTED PUBLICATIONS As of June 28th , 2017

Upload: nguyentram

Post on 17-Feb-2019

216 views

Category:

Documents


0 download

TRANSCRIPT

FIRST and FAMILY NAME

Carmine Zoccali

DATE OF BIRTH

27th Jan 1947

HIGHEST DEGREE (e.g. full professor, clinical or post-

graduate professor, doctor)

Post-Graduate Professor of Nephrology

HONORS (e.g. FERA, FASN, FAKF, etc.)

1. FERA (Fellow of the European Renal Association) 2. FASN (Fellow of the American Society of Nephrology) 3. FAKF(Fellow of the American Kidney Foundation)

PRESENT POSITION

Associated Investigator and Research Coordinator CNR-IFC Research on Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension, Reggio Calabria, ITALY

PRESENT EDITORIAL POSITIONS in International and National Journals (up to seven)

As of June 28th , 2017

- Editorial Board member J Am Soc Nephrology

- Editorial Board Member Hypertension

- Academic editor PlosOne (Public Library of Science, National Institute of Health)

- Associate Editor European Journal of Clinical Investigation

- Editorial Board member Clinical Nephrology

- Editorial Board member Nutrition Metabolism and Cardiovascular Diseases

- Editorial Board Member BMC Nephrology

AREA OF EXPERTISE (basic, clinical, both) Please also

indicate the specific area of interest (e.g. CKD progression, kidney failure, Hypertension, GNitis and Immunopathology, etc.)

Hypertension, Cardiovascular Complications in CKD, CKD progression, Epidemiology and Molecular Epidemiology of the risk for CV complications of CKD disease and CKD Progression.

NUMBER OF PUBMED PUBLICATIONS

As of June 28th, 2017 638 PubMed indexed publications.

5 MOST QUOTED PUBLICATIONS

As of June 28th , 2017

Martini
Font monospazio
CURRICULUM VITAE
Martini
Font monospazio

Kindly specify the number of quotations of each publication 1. Zoccali C, Bode-Böger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frölich J, Böger Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001; 358:2113-7. 994 quotations

2. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002; 13:134-41. 946 quotations

3. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999; 354:359-64. 862 quotations

4. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003; 18:1272-80. 659 quotations 5. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G, Malatino LS, Böger R. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol. 2002; 13:490-6 360 quotations

HIRSCH-INDEX Kindly specify if your HI is calculated by Publish or Perish (PoP) or by WEB of Science (WoS)

As of June 28th , 2017 84 (Google Scholar) 64 (WoS) 90 (PoP, Publish or Perish)

INTERNATIONAL AWARDS

-International Award of the American Kidney Foundation (2003)

-International G.A. Borelli prize (2004)

-Honorary member of the Polish Society of Nephrology (2007)

-Honorary Member of the Spanish Society of Nephrology (2008)

-Fellow of the American Society of Nephrology (FASN) 2008

-Fellow of the National Kidney Foundation (FNKF) 2010

-Fellow of the European Renal Association and the European Dialysis and Transplantation Society (FERA) 2010

-Dorso Prize (2010)